Peripheral T - cell lymphomas (PTCL) represent a heterogeneous clinicopathological entity of non-Hodgkin lymphoma with
an aggressive disease course and poor clinical outcome.
«Building upon previous data related to the PRSS1 mutations found in patients with early - onset pancreatitis, we learned that combined with our current data, patients with PRSS1 are more likely to have
an aggressive disease course,» said Giefer.
Not exact matches
«This would be useful and important,» he said, «because physicians could decide to switch or modify therapies if they know whether the patient is likely to have an
aggressive course of
disease, or a more benign
course.»